Open Access

Erratum to: Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort

Arthritis Research & Therapy201517:236

https://doi.org/10.1186/s13075-015-0752-9

Received: 10 August 2015

Accepted: 10 August 2015

Published: 2 September 2015

The original article was published in Arthritis Research & Therapy 2015 17:120

Unfortunately, the original version of this article [1] contained an error. The Fig. 1 was included incorrectly. The correct Fig. 1 can be found below.
Fig. 1

Notes

Declarations

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Medicine Service and Center for Surgical Medical Acute care Research and Transitions (C-SMART), Birmingham VA Medical Center
(2)
Department of Medicine at School of Medicine, University of Alabama
(3)
Division of Epidemiology at School of Public Health, University of Alabama
(4)
Department of Orthopedic Surgery, Mayo Clinic College of Medicine
(5)
Takeda Pharmaceuticals International, Inc.
(6)
University of Alabama

Reference

  1. Singh JA, Akhras KS, Shiozawa A. Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort. Arthritis Res Ther. 2015;17:120.PubMedView ArticlePubMed CentralGoogle Scholar

Copyright

© Singh et al. 2015

Advertisement